Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.

World journal of gastroenterology - 14 Apr 2020

O'Neill Robert Sean, Emmanuel Sam, Williams David, Stoita Alina

Abstract excerpt

BACKGROUND: Pancreatic cancer (PC) is a leading cause of cancer related mortality worldwide, with poor survival due to late diagnosis. Currently, biomarkers have limited use in early diagnosis of PC. Macrophage inhibitory cytokine-1 or growth differentiation factor-15 (MIC-1/GDF15) has been implicated as a potential serum biomarker in PC and other malignancies. AIM: To determine the role of MIC-1/GDF15 in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asymptomatic Diseases
Share to Australia

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Endosonography

Share to Pancreas

Share to Pilot Projects

Share to Precancerous Conditions

Share to ROC Curve

Source

Open in PubMed Open full text

Identifiers

PMID: 32327914
DOI: 10.3748/wjg.v26.i14.1660
PMCID: PMC7167415

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.PMID 32327914Read ↗

Pancreatic Cancer Detection in Intraductal Papillary Mucinous Neoplasm (IPMN) – New InsightsSemantic proximity Read ↗

An integrated multi-omics biomarker approach using molecular profiling and microRNAs for evaluation of pancreatic cyst fluid.Semantic proximity Read ↗

Proteomic Mucin Profiling for the Identification of Cystic Precursors of Pancreatic CancerSemantic proximity Read ↗

A Genome-Wide Investigation of MicroRNA Expression Identifies Biologically-Meaningful MicroRNAs That Distinguish between High-Risk and Low-Risk Intraductal Papillary Mucinous Neoplasms of the PancreasSemantic proximity Read ↗

Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.Semantic proximity Read ↗

Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

Growth differentiation factor 15 and its role in carcinogenesis: an updateSemantic proximity Read ↗

MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease ControlsSemantic proximity Read ↗

Changes to management influenced by next-generation sequencing of pancreatic duct aspirates among patients with main pancreatic duct dilatation of unclear etiology: a multicenter cohort study.Semantic proximity Read ↗

Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15) Gene Deletion Promotes Cancer Growth in TRAMP Prostate Cancer Prone MiceSemantic proximity Read ↗

PD1+ T-cells correlate with Nerve Fiber Density as a prognostic biomarker in patients with resected perihilar cholangiocarcinomaSemantic proximity Read ↗

Upregulated GDF-15 expression facilitates pancreatic ductal adenocarcinoma progression through orphan receptor GFRALSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.